What's happening
This bill requires healthcare practitioners to report any administration of naloxone or other overdose reversal agents to the prescription monitoring program within 72 hours.
Why it matters
Creates a new data stream for overdose incidents. By requiring practitioners to report every use of naloxone or similar agents to the prescription monitoring program (PMP), the bill ensures that overdose events are systematically tracked, which could inform public health responses and resource allocation.
Links overdose care to patient records. Because reported information (patient name, address, date of birth, time/place of administration, and reporter identity) is connected to the PMP, it could facilitate follow-up care, risk assessment, or intervention for individuals with repeated overdoses.
Expands the role of the PMP beyond prescriptions. The program, originally designed to monitor controlled substance prescriptions, would now also gather information on acute overdose events, potentially enhancing its utility as a tool for understanding and combating the opioid crisis.
May affect practitioner workflow and privacy considerations. The new reporting requirement adds an administrative step for healthcare providers and could raise concerns about patient confidentiality, especially if sensitive information about overdose incidents is more widely accessible.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Report Naloxone Use to Registry
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Print number 4374b
- Amend (t) and recommit to health
- Print number 4374a
- Amend and recommit to health
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Report All Naloxone Uses
In Assembly Committee · Codes · Sponsor John T. McDonald III
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4374--B
2017-2018 Regular Sessions
IN SENATE
February 10, 2017
Introduced by Sen. AMEDORE -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- recommitted to the Committee on Health in accordance with Senate Rule 6, sec. 8 -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 9 of section 3343-a of the public health law is renumbered subdivision 10 and a new subdivision 9 is added to read as follows:
9. Administration of overdose reversal agents. (a) Any practitioner who administers naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose shall report the administration of the agent to the prescription monitoring program registry within seventy-two hours of administration. Such report shall contain the following information if available: (i) the name of the patient; (ii) the address of the patient; (iii) the date of birth of the patient; (iv) the time and place of the administration of the agent; and (v) the identity of the person who administered the naloxone to the patient.
(b) Any report made pursuant to the terms of this subdivision shall be considered to be made by the reporter in the course of his or her duties and shall be directly related to patient care.
§ 2. This act shall take effect January 1, 2020.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07660-07-8
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to requiring practitioners who administer naloxone or another overdose reversal agent to a patient in the case of a suspected or confirmed overdose to report the administration of the agent to the prescription monitoring program registry
Purpose or general idea of bill
Directs that the department of health include information regarding the administration of overdose reversal agents on the prescription monitor- ing program registry.
Summary of specific provisions
Section 1. Renumbers Subdivision 9 of section 3343-a of the public health law as subdivision 10 and creates a new subdivision 9
Section 2. Establishes an effective date of January 1, 2020.
Justification
The goal of this bill is to request that the NYS DOH develop and imple- ment an advancement to the NYS Prescription Monitoring Program (PMP) to help prescribers identify patients that have had overdosed on either an opioid or heroin.
The idea is to develop an alert tag in the PMP for prescribers so that when they access the PMP for their patient's care they will be able to identify if a patient had an overdose in the past. This data on over- doses is collected by the New York State Department of Health since Health Care Facilities licensed in New York State, under Article 28 of the Public Health Law, are required to submit their inpatient and/or outpatient data to SPARCS. Data such as ICD-10 codes are collected which will identify all drug overdoses, opioid drug overdoses and heroin over- doses. This information can be converted to help add an alert flag in the PMP which prescribers will notice when prescribing controlled substances. This alert will allow the prescriber to open up a dialogue with the patient about the overdose and what modifications or therapies can be considered to prevent an overdose in the future.
The bill would require all medical practitioners whom administer nalox- one to report to the PMP within 72 hours of administration of the agent the following information, if available:
*Name of Patient *Address of Patient *DOB of patient *Time and Place of Administration
The result of providing this information is to assist practitioners in identifying a patient who had an overdose and to open up an opportunity for the patient and prescriber to have a discussion about treatment.
The inspiration for this bill comes from a study recently released by a major commercial insurance plan, Optum. They identified almost 3,000 patients who experienced a nonfatal overdose between 2000 and 2012 while taking long-term opioids prescribed for chronic pain not related to cancer. Opioids include drugs like codeine, oxycodone, hydrocodone, hydromorphone, and tramadol. Just over 90% of these patients continued to receive prescription opioids after the overdose. More than half got the prescription from the same doctor.
Prescribers must have all the tools at their disposal to prevent, diag- nose and treat drug addiction. It is incomprehensible that individuals can narrowly avoid dying of an overdose and be back at their prescriber's office acquiring a prescription for the item that almost killed them. This bill will prevent senseless deaths and hopefully lead those with addictions toward treatment and recovery.
Prior legislative history
2015-16 A.10656
Fiscal implications
None to the State.
Effective date
January 1, 2020.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.